share_log

HAVN Life Sciences Inc. (OTCMKTS:HAVLF) Short Interest Update

HAVN Life Sciences Inc. (OTCMKTS:HAVLF) Short Interest Update

HAvn生命科学公司(场外交易代码:HAVLF)空头股数更新
kopsource ·  2022/12/02 10:34

HAVN Life Sciences Inc. (OTCMKTS:HAVLF – Get Rating) was the target of a significant growth in short interest in the month of November. As of November 15th, there was short interest totalling 15,100 shares, a growth of 62.4% from the October 31st total of 9,300 shares. Based on an average daily volume of 30,400 shares, the short-interest ratio is currently 0.5 days.

HAvn Life Science Inc.(场外市场代码:HAVLF-GET Rating)是11月份空头股数显著增长的目标。截至11月15日,空头股数共有15,100股,较10月31日的9,300股增长62.4%。以日均成交量30,400股计算,短息比目前为0.5天。

HAVN Life Sciences Trading Up 17.9 %

HAVN生命科学公司股价上涨17.9%

HAVN Life Sciences stock traded up $0.01 during midday trading on Friday, reaching $0.07. 1,760 shares of the company's stock were exchanged, compared to its average volume of 5,533. HAVN Life Sciences has a 52 week low of $0.05 and a 52 week high of $6.00. The stock's 50-day simple moving average is $0.07 and its 200 day simple moving average is $0.67.

在周五午盘交易中,哈文生命科学的股票上涨了0.01美元,达到0.07美元。该公司股票成交量为1,760股,而平均成交量为5,533股。HAvn Life Sciences的52周低点为0.05美元,52周高位为6.00美元。该股的50日简单移动均线切入位为0.07美元,200日简单移动均线切入位为0.67美元。

Get
到达
HAVN Life Sciences
拥有生命科学学位
alerts:
警报:

HAVN Life Sciences Company Profile

HAVN生命科学公司简介

(Get Rating)

(获取评级)

HAVN Life Sciences Inc, a biotechnology company, engages in the research and development of psychopharmacological products from plants and fungi. The Company also focuses on developing methodologies for the standardize and quality-controlled extraction of psychoactive compounds from plants and fungi, including Psilocybe spp.
HAVN生命科学公司是一家生物技术公司,从事从植物和真菌中提取的精神药理产品的研究和开发。该公司还专注于开发从植物和真菌(包括裸子菌属)中标准化和质量控制地提取精神活性化合物的方法。

Featured Articles

专题文章

  • Get a free copy of the StockNews.com research report on HAVN Life Sciences (HAVLF)
  • Institutions Are Buying Ambarella, Should You?
  • Can ZIM Defy Broad Downturn In The Container Shipping Industry?
  • Ford Revving Up Production Of EV Power Units At U.K. Plant
  • Are the Short Sellers Still Right About Mullen Automotive stock?
  • La-Z-Boy Reclines To More Comfortable Levels
  • 免费获取StockNews.com关于HAVN生命科学的研究报告(HAVLF)
  • 机构正在购买安巴雷拉,你应该吗?
  • ZIM能否抵御集装箱航运业的普遍低迷?
  • 福特在英国工厂加速生产电动汽车动力装置
  • 卖空者对马伦汽车股票的看法仍然正确吗?
  • La-Z-Boy倾斜到更舒适的水平

Receive News & Ratings for HAVN Life Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HAVN Life Sciences and related companies with MarketBeat.com's FREE daily email newsletter.

接受《HAVN生命科学日报》的新闻和评级-在下面输入您的电子邮件地址,通过MarketBeat.com的免费每日电子邮件时事通讯接收对HAVN生命科学和相关公司的最新新闻和分析师评级的每日简要摘要。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发